5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 2.15▲ | 2.14▲ | 2.14▲ | 2.10▲ | 2.47▼ |
MA10 | 2.17▲ | 2.17▲ | 2.17▲ | 2.19▼ | 2.42▼ |
MA20 | 2.19▲ | 2.20▼ | 2.21▼ | 2.45▼ | 2.45▼ |
MA50 | 2.38▼ | 2.68▼ | 2.64▼ | 2.40▼ | N/A |
MA100 | 3.15▼ | 2.59▼ | 2.47▼ | 2.45▼ | N/A |
MA200 | 3.02▼ | 2.53▼ | 2.47▼ | 2.75▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.021▲ | 0.024▲ | 0.019▲ | -0.049▼ | 0.055▲ |
RSI | 45.507▼ | 44.566▼ | 45.193▼ | 45.464▼ | 40.787▼ |
STOCH | 45.614 | 35.058 | 35.759 | 13.480▼ | 36.318 |
WILL %R | -22.727▲ | -22.727▲ | -29.167 | -80.291▼ | -92.953▼ |
CCI | 21.287 | 47.863 | 41.604 | -57.900 | -94.194 |
Monday, September 22, 2025 08:02 AM
BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ), , a clinical-stage biotechnology company developing novel immunotherapies to transform cancer care, announced the publication of the mechanism ...
|
Sunday, September 14, 2025 03:45 AM
BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ) , a clinical-stage biotechnology company developing novel immunotherapies to transform cancer care, announces the addition of UCLA Health ...
|
Friday, September 12, 2025 09:56 AM
Kendrew Hartanto, CEO of BrilliA (NYSE: BRIA), shares how the company stitched its path to IPO and redefined leadership in women’s undergarments.
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
25/09/25 | 2.01 | 2.27 | 1.99 | 2.18 | 71,700 |
24/09/25 | 2.02 | 2.10 | 1.97 | 2.02 | 42,516 |
23/09/25 | 2.11 | 2.16 | 2.07 | 2.07 | 29,300 |
22/09/25 | 2.13 | 2.1564 | 2.10 | 2.11 | 43,082 |
19/09/25 | 2.209 | 2.235 | 2.10 | 2.10 | 50,300 |
18/09/25 | 2.17 | 2.31 | 2.05 | 2.18 | 88,000 |
17/09/25 | 2.22 | 2.30 | 2.17 | 2.20 | 72,347 |
16/09/25 | 2.36 | 2.38 | 2.121 | 2.15 | 82,114 |
15/09/25 | 2.44 | 2.49 | 2.32 | 2.32 | 266,300 |
12/09/25 | 2.43 | 2.59 | 2.38 | 2.55 | 617,500 |
|
|
||||
|
|
||||
|
|